PRESS RELEASE published on 09/12/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces participation in the 59th Annual Inner Ear Biology Workshop in Warsaw, Poland. Presentation on SENS-401 and gene therapy programs Gene Therapy Sensorion Hearing Loss SENS-401 Inner Ear Biology Workshop
BRIEF published on 09/02/2024 at 07:35, 1 year 4 months ago Sensorion at the World Congress of Audiology 2024 in Paris Gene Therapy Sensorion Hearing Loss World Congress Of Audiology Medical Symposium
PRESS RELEASE published on 09/02/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion to lead symposium on medical advances in hearing loss at World Congress of Audiology in Paris, September 2024 Sensorion Hearing Loss Symposium World Congress Of Audiology Medical Advances
BRIEF published on 08/05/2024 at 07:35, 1 year 5 months ago Sensorion to Participate in Stifel's Biotech Summer Summit Investment Gene Therapy Sensorion Hearing Loss Biotech Summit 2024
PRESS RELEASE published on 08/05/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion to participate in Stifel's Biotech Summer Summit 2024 to discuss strategic developments and gene therapy programs for hearing loss disorders Gene Therapy Sensorion Hearing Loss Disorders Stifel Biotech Summer Summit
BRIEF published on 06/27/2024 at 07:35, 1 year 7 months ago Sensorion Announces Appointment of New Chief Financial Officer Chief Financial Officer Biotechnology Sensorion Hearing Loss Laurene Danon
PRESS RELEASE published on 06/27/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion appoints Laurene Danon as Chief Financial Officer, bringing 15 years of experience in investment banking. The company focuses on developing therapies for hearing loss disorders Chief Financial Officer Investment Banking Sensorion Laurene Danon Hearing Loss Therapies
BRIEF published on 05/30/2024 at 07:35, 1 year 7 months ago Sensorion announces the results of its Combined General Meeting Biotechnology Resolutions General Assembly Sensorion Hearing Therapies
BRIEF published on 05/28/2024 at 07:35, 1 year 8 months ago Sensorion Announces Participation in June 2024 Investor Conferences Biotechnology Investor Conferences Healthcare Sensorion Hearing Loss
PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 8 months ago Inside Information / Other news releases Sensorion announces its participation in upcoming investor conferences in June 2024 to present its novel therapies for hearing loss disorders. The company will attend conferences in New York, Miami, and Lyon Biotechnology Investor Conferences June 2024 Sensorion Hearing Loss Disorders
Published on 01/29/2026 at 03:30, 3 hours 32 minutes ago NuRAN Provides Clarification and Corrections Regarding Restructuring Transaction Disclosure
Published on 01/29/2026 at 02:15, 4 hours 47 minutes ago McEwen Inc. to Acquire Golden Lake Exploration Inc.
Published on 01/29/2026 at 01:50, 5 hours 12 minutes ago Alphinat Announces a Net Profit of $89,282 for Quarter Ended November 30, 2025
Published on 01/29/2026 at 00:00, 7 hours 2 minutes ago Tokenwell Adds Single-Coin Trading Capabilities and Expands Exchange Support
Published on 01/28/2026 at 23:45, 7 hours 17 minutes ago CoTec Holdings Corp. Announces Warrant Exercise by Kings Chapel
Published on 01/29/2026 at 06:58, 4 minutes ago After Record Year: DWS Exceeds Strategic Mid-term Targets and Increases Ambitions Until 2028
Published on 01/29/2026 at 06:57, 5 minutes ago Emmi continues its growth dynamic and convinces with innovative strength
Published on 01/29/2026 at 06:50, 12 minutes ago Piramal Pharma Limited Announces Results for Q3 and 9M FY26
Published on 01/28/2026 at 18:00, 13 hours 2 minutes ago Launch of Skira Education Systems and acquisition of Institut Beau Cèdre
Published on 01/28/2026 at 17:45, 13 hours 17 minutes ago Infotel : Q4 2025 revenue up +3.5%. Acquisition of Sesin, a specialist in EDM. A promising start to 2026
Published on 01/28/2026 at 17:40, 13 hours 22 minutes ago Mersen: Sales of €1.2 billion in 2025, in line with expectations
